Vitrolife AB (publ) (VITR.ST)
- Previous Close
155.40 - Open
155.50 - Bid 157.60 x --
- Ask 157.90 x --
- Day's Range
155.50 - 158.70 - 52 Week Range
142.90 - 268.00 - Volume
132,179 - Avg. Volume
232,339 - Market Cap (intraday)
21.414B - Beta (5Y Monthly) 1.83
- PE Ratio (TTM)
43.08 - EPS (TTM)
3.67 - Earnings Date Jul 17, 2025
- Forward Dividend & Yield 1.10 (0.70%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
242.40
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
www.vitrolife.comRecent News: VITR.ST
View MorePerformance Overview: VITR.ST
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VITR.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VITR.ST
View MoreValuation Measures
Market Cap
21.41B
Enterprise Value
22.31B
Trailing P/E
43.08
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.94
Price/Book (mrq)
1.63
Enterprise Value/Revenue
6.18
Enterprise Value/EBITDA
29.59
Financial Highlights
Profitability and Income Statement
Profit Margin
13.80%
Return on Assets (ttm)
2.89%
Return on Equity (ttm)
3.78%
Revenue (ttm)
3.61B
Net Income Avi to Common (ttm)
498M
Diluted EPS (ttm)
3.67
Balance Sheet and Cash Flow
Total Cash (mrq)
1.05B
Total Debt/Equity (mrq)
14.86%
Levered Free Cash Flow (ttm)
574.25M